This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,752.03 firm fixed-price contract is for the delivery of XELJANZ XR 11 MG TABLET products to support federal healthcare programs. The contract has an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,853.84, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a specialty pharmaceutical product. The contract has a completion date of December 27, 2024 and is a firm fixed-price contract. This award is associated with a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,426.83 firm-fixed-price contract is for the delivery of XELJANZ XR 11 MG TABLET. It has a period of performance through May 2, 2024. The award is not associated with a set-aside program. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,204.71, is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,798.83, is for the delivery of XELJANZ XR 11 MG Tablet prescription medication. The contract has an ultimate completion date of January 16, 2025 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,118.90 contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of January 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,757.10, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm fixed price delivery order, with a period of performance through May 12, 2025. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,618.23, is for the delivery of XELJANZ XR 11 MG TABLET 30S to support federal healthcare programs. The contract is a firm fixed-price, delivery order type, with a period of performance through December 12, 2024. This award is not designated as a set-aside...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,621.77, is for the provision of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has a period of performance through July 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,395.89, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S and has an ultimate completion date of April 1, 2025. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...